Please provide your email address to receive an email when new articles are posted on . Researchers have developed a risk model to help predict the chances of adverse events after a patient receives ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care -- although a ...

Traditionally implantable cardioverter defibrillators (ICDs) have been implanted transvenously by creating a pouch in the subclavicular area and gaining vascular access to the heart. This approach, ...

On February 15, 2018, CMS released a final policy decision updating the national coverage determination (NCD) governing implantable cardioverter defibrillator (ICD) implantation for Medicare ...

Improvements in optimal medical therapy for patients with heart failure with reduced ejection fraction (HFrEF) have helped reduce the risk of sudden cardiac death (SCD)—in the modern era, though, just ...

This study demonstrates the following: (1) Although DFT testing is still performed in most (71%) patients, it is not performed in 29% of patients who undergo initial ICD implantation in the United ...

Edoardo Bove will undergo a small procedure to insert a removable implantable cardioverter defibrillator on Tuesday. If all goes well, he’ll be discharged from the hospital by the end of the week.

The FDA today approved the Subcutaneous Implantable Defibrillator (S-ICD) system from Cameron Health. The device is the first ICD that does not require a lead that connects directly to the heart and ...